The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 81 | — | 20.1x | Above average | |
Growth | 20 | 1.2% | 5.6% | Below average | |
Quality | 31 | -24.1% | 7.6% | Below average | |
Safety | 48 | -1.2x | 0.4x | Near average | |
Capital Return | 86 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Integra LifeSciences Holdings Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Integra LifeSciences Holdings Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
IART stock is experiencing a state of collective pessimism among analysts, with the price target stabilizing at 12 dollars, representing a discount of approximately 25% from the current price of 16.1 dollars. Notably, the number of analysts covering the stock has decreased from 6 to 3 over the past thirty days, with a complete alignment in their targets (12 dollars as both minimum and maximum), indicating Zero Dispersion and a consensus on a valuation lower than the current market value.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.